Page last updated: 2024-08-17

adenosine monophosphate and Diffuse Parenchymal Lung Disease

adenosine monophosphate has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Babusis, D; Bosio, CM; Cihlar, T; de Wit, E; Feldmann, F; Haddock, E; Hanley, PW; Holbrook, MG; Lovaglio, J; Lye, DS; Mackman, RL; Okumura, A; Pérez-Pérez, L; Porter, DP; Saturday, G; Schwarz, B; Singh, M; Subramanian, R; Williamson, BN	1
Alcobendas, R; Álvarez-Rojas, E; de la Serna, O; Laplaza-González, M; Murias, S; Quintana-Ortega, C; Remesal, A; Ruiz de Valbuena, M; Udaondo, C	1

Other Studies

2 other study(ies) available for adenosine monophosphate and Diffuse Parenchymal Lung Disease

Article	Year
Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2. Antiviral research, 2022, Volume: 198 Topics: Adenosine Monophosphate; Administration, Cutaneous; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Disease Models, Animal; Female; Lung; Lung Diseases, Interstitial; Macaca mulatta; Male; SARS-CoV-2; Viral Load; Virus Replication	2022
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report. Modern rheumatology case reports, 2021, Volume: 5, Issue:1 Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination	2021

Article

Year

Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2.

Antiviral research, 2022, Volume: 198

Topics: Adenosine Monophosphate; Administration, Cutaneous; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Disease Models, Animal; Female; Lung; Lung Diseases, Interstitial; Macaca mulatta; Male; SARS-CoV-2; Viral Load; Virus Replication

2022

Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.

Modern rheumatology case reports, 2021, Volume: 5, Issue:1

Topics: Adenosine Monophosphate; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Autoantibodies; Bronchoscopy; Child; COVID-19; COVID-19 Nucleic Acid Testing; Cyclophosphamide; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Methylprednisolone; Piperidines; Pneumonia, Pneumocystis; Pneumothorax; Pyrimidines; Respiratory Insufficiency; Shock, Septic; Subcutaneous Emphysema; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination

2021